Zdrowie i gospodarka · 03/10/2017

FDA Hosts Public Workshop to Overcome Barriers to Generic Topical Dermatological Drug Development and Improve Patient Access

The FDA is hosting a public workshop to discuss regulatory science initiatives for generic topical dermatological drugs, gather public input on barriers to access, and explore ways to overcome them, with input from industry, academia, patient advocates, and professional associations.